Lifetime costs of surgical versus medical treatment of severe gastro- oesophageal reflux disease in Finland

Scandinavian Journal of Gastroenterology

Volumn 32, Issue 8, 1997, Pages 766-772

  Viljakka, M ^a   Nevalainen, J ^b   Isolauri, J ^b  

^a TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

^b NONE

Author keywords

Antireflux surgery; Gastro oesophageal reflux disease; H2 blockers; Proton pump inhibition

Indexed keywords

HISTAMINE H2 RECEPTOR ANTAGONIST; LANSOPRAZOLE; OMEPRAZOLE; PROTON PUMP INHIBITOR; RANITIDINE;

ADULT; AGED; ANTIREFLUX OPERATION; ARTICLE; DRUG COST; FEMALE; FINLAND; GASTROESOPHAGEAL REFLUX; HEALTH CARE COST; HUMAN; LAPAROSCOPIC SURGERY; MALE; PRIORITY JOURNAL; STOMACH FUNDOPLICATION;

EID: 0030837513     PISSN: 00365521     EISSN: None     Source Type: Journal    
DOI: 10.3109/00365529708996532     Document Type: Article

References (29)

1. Isolauri J, Laippala P. Prevalence of symptoms suggestive of gastrooesophageal reflux disease in an adult population. Ann Med 1995;27:67-70.
2. Nebel TO, Fornes MF, Castell DO. Symptomatic gastroesophageal reflux: incidence and precipitating factors. Dig Dis Sci 1976;21:953-6.
3. Wienbeck M, Barnert J. Epidemiology of reflux disease and reflux esophagitis. Scand J Gastroenterol 1989;24 Suppl 156:7-13.
4. Kitchin LI, Castell DO. Rationale and efficacy of conservative treatment for gastroesophageal reflux disease. Arch Intern Med 1991;151:448-54.
5. Havelund T, Laursen LS, Skoubo-Kristensen E, Andersen BN, Pedersen SA, Jensen KB, et al. Omeprazole and ranitidine in treatment of reflux oesophagitis: double blind comparative trial. Br Med J 1988;296:89-92.
6. Sandmark S, Carlsson O, Fausa O, Lundell L. Omeprazole or ranitidine in the treatment of reflux esophagitis. Results of a double blind, randomized, Scandinavian multicenter study. Scand J Gastroenterol 1988;23:625-32.
7. Laursen LS, Havelund T, Bondesen S, Hansen J, Sanchez G, Sebelin E, et al. Omeprazole in the long-term treatment of gastro-oesophageal reflux disease. A double-blind randomized dose-finding study. Scand J Gastroenterol 1995;30:839-46.
8. Dent J, Yeomans ND, Mackinnon M, Reed W, Narielvala FM, Hetzel DJ, et al. Omeprazole v. ranitidine for prevention of relapse in reflux oesophagitis. A controlled double blind trial of their efficacy and safety. Gut 1994;35:590-8.
9. Luostarinen M. Nissen fundoplication for reflux esophagitis. Long-term clinical and endoscopie results in 109 of 127 consecutive patients. Ann Surg 1993;217:329-37.
10. Johansson J, Johnsson F, Joelsson B, Florén C-H, Walther B. Outcome 5 years after 360° fundoplication for gastro-oesophageal reflux disease. Br J Surg 1993;80:46-9.
11. DeMeester TR, Bonavina L, Albertucci M. Nissen fundoplication for gastroesophageal reflux disease: evaluation of primary repair in 100 consecutive patients. Ann Surg 1986;204:9-20.
12. Negre JB, Markkula HT, Keyriläinen O, Matikainen M. Nissen fundoplication. Results at 10 year follow-up. Am J Surg 1983; 146:635-8.
13. Shirazi S, Schulze K, Soper R. Long-term follow-up for treatment of complicated chronic reflux esophagitis. Arch Surg 1987;122:548-52.
14. Spechler S, Department of Veterans Affairs Gastroesophageal Reflux Disease Study Group. Comparison of medical and surgical therapy for complicated gastroesophageal reflux disease in veterans. N Engl J Med 1992;326:786-92.
15. Isolauri J, Luostarinen M, Isolauri E, Reinikainen P, Viljakka M, Keyriläinen O. Natural course of gastroesophageal reflux disease; 17-22 year follow-up of 60 patients. Am J Gastroenterol 1997;92:37-41.
16. Stein HJ, DeMeester TR. Who benefits from antireflux surgery? World J Surg 1992;16:313-9.
17. Hetzel DJ, Dent J, Reed WD, Narielvala FM, Mackinnon M, McCarthy JH, et al. Healing and relapse of severe peptic esophagitis after treatment with omeprazole. Gastroenterology 1988;95:903-12.
18. Van Den Boom G, Go PMMYH, Hameeteman W. Dallemagne B, Ament AJHA. Cost effectiveness of medical versus surgical treatment in patients with severe or refractory gastroesophageal reflux disease in the Netherlands. Scand J Gastroenterol 1996;31:1-9.
19. Coley CM, Barry MJ, Spechler SJ, Williford WO, Mulley AG. Initial medical v. surgical therapy for complicated or chronic gastroesophageal reflux disease (GERD). A cost-effectiveness analysis. Gastroenterology 1993;104:A5.
20. 2RA) or omeprazole (OM). Gastroenterology 1990;98:A18.
21. Garnett WR. Efficacy, safety, and cost issues in managing patients with gastroesophageal reflux disease. Am J Hosp Pharm 1993;50 Suppl 1:S11-8.
22. Hillman AL. Economic analysis of alternative treatments for persistent gastro-oesophageal reflux disease. Scand J Gastroenterol 1994;29 Suppl 201:98-102.
23. Lundell L, Backman L, Ekström P, Enander L-K, Falkmer S, Fausa O, et al. Prevention of relapse of reflux esophagitis after endoscopie healing: the efficacy and safety of omeprazole compared with ranitidine. Scand J Gastroenterol 1991;26:248-56.
24. 2-receptor antagonists. Scand J Gastroenterol 1989;24 Suppl 166:88-93.
25. O'Hanrahan T, Marples M, Bancewicz J. Recurrent reflux and wrap disruption after Nissen fundoplication: detection, incidence and timing. Br J Surg 1990;77:545-7.
26. Kuipers EJ, Lundell L, Klinkenberg-Knol EC, Havu N, Festen HPM, Liedman B, et al. Atrophic gastritis and Helicobacter pylori infection in patients with reflux esophagitis treated with omeprazole or fundoplication. N Engl J Med 1996;334: 1018-22.
27. Kauer WKH, Peters JH, DeMeester TR, Ireland AP, Bremner CG, Hagen JA. Mixed reflux of gastric and duodenal juices is more harmful to the esophagus than gastric juices alone. The need for surgical therapy re-emphazised. Ann Surg 1995;222: 525-33.
28. Stein HJ, Barlow AP, DeMeester TR, Hinder RA. Complications of gastroesophageal reflux disease. Role of the lower esophageal sphincter, esophageal acid and acid/alkaline exposure, and duodenogastric reflux. Ann Surg 1992;216:35-43.
29. Isolauri J, Luostarinen M, Viljakka M, Isolauri E, Keyriläinen O, Karvonen A-L. Long-term comparison of antireflux surgery vs conservative therapy for reflux esophagitis. Ann Surg 1997;225:295-9.